HOME › DRUGS › ABROCITINIB
ACTIVE SUBSTANCE / INN

ABROCITINIB

Brand name(s): CIBINQO, Cibinqo
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA213871
Dermatitis, Atopic
ACTIVE SUBSTANCE
Abrocitinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Pfizer Europe MA EEIG, PFIZER
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CIBINQONDA213871PFIZERPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CibinqoPfizer Europe MA EEIGAuthorised09/12/2021Dermatitis, Atopic

FULL INTELLIGENCE ON ABROCITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →